Learn more about how we are reimagining the world

Major Multinational Pharma Company Leads Series B "Extension Round" for ActivSurgical

Hikma Pharmaceuticals, the multinational pharmaceutical company, today announced that its venture capital arm has led a $15M round of financing for Activ Surgical, a pioneering digital surgery imaging startup that is developing groundbreaking interoperative surgical intelligence hardware and software. The investment is an extension of the Series B round that was previously announced by Activ Surgical in September 2021. This most recent financing, which also saw participation from existing investors, brings the total Series B round to $60M.

March 28, 2022